AzTrials
AzTrials

Rheumatoid ArthritisNCT02397798

Improved Ability to Cope With Everyday Life Through a Person-centered Training Program in Elderly Patients With Rheumatoid Arthritis - PEP-walk Study

A study testing Person-centered high-intense training under supervision and Personalized exercise program to perform at home in people with Rheumatoid Arthritis, run by Vastra Gotaland Region at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to examine whether person-centered high-intense aerobic / strength training during five months reduces inflammation and disease activity, improve immune cell function, and increases muscle strength, fitness and ability of the individual independence in elderly patients with rheumatoid… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Rheumatoid Arthritis
What is being tested?
Person-centered high-intense training under supervision and Personalized exercise program to perform at home
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteSweden
Study dates
Feb 2015to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patients 65 years or older with RA diagnosed according to the ACR / EULAR 1987/2010 criteria,
  • disease duration 2 years or more,
  • disease activity as measured by DAS28 <5.1

Who cannot join

  • Comorbidities, such as unstable coronary artery disease, uncontrolled cardiac arrhythmia, or uncontrolled high blood pressure, which prevents moderate to intense exercise.
  • Joint surgery completed within 6 months prior to study entry.
  • Ongoing training at moderate to high level 2 or more times per week

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • VastraGotaland

    Gothenburg

Other trials in Sweden

About this study

The purpose of this study is to examine whether person-centered high-intense aerobic / strength training during five months reduces inflammation and disease activity, improve immune cell function, and increases muscle strength, fitness and ability of the individual independence in elderly patients with rheumatoid arthritis.

Being tested
Person-centered high-intense training under supervision, Personalized exercise program to perform at home
Medical subject headings
Arthritis, Rheumatoid

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Person-centered high-intense training under supervisionBehavioural

    A person-centered training program including a person-centered high-intense aerobic / strength training

  • Personalized exercise program to perform at homeBehavioural

    Introduction to health-enhancing physical activity, personalized exercise program to perform at home three times a week

Study groups in NCT02397798
Study groupRoleWhat they receive
InterventionExperimentalPerson-centered high-intense training three times a week under supervision (supervision two times a week) during 5 months
Receives: Behavioral: Person-centered high-intense training under supervision
ControlActive comparatorIntroduction to health-enhancing physical activity, personalized exercise program to perform at home three times a week during 5 months
Receives: Behavioral: Personalized exercise program to perform at home

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ability to manage daily activities as measured by the rheumatoid arthritis-specific measure of the Health Assessment Questionnaire (HAQ).

    Measured: 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Mar 2015 (estimated)
  2. Study startFeb 2015
  3. Primary completionDec 2017
  4. Study completionDec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
75 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02397798
Sponsor's protocol ID
PEp-walk study
Status last verified
Jun 2020
First submitted
19 Mar 2015
Last updated
19 Apr 2021
Results posted
No

Publications

  • Andersson SEM, Lange E, Kucharski D, Svedlund S, Onnheim K, Bergquist M, Josefsson E, Lord JM, Martensson IL, Mannerkorpi K, Gjertsson I. Moderate- to high intensity aerobic and resistance exercise reduces peripheral blood regulatory cell populations in older adults with rheumatoid arthritis. Immun Ageing. 2020 May 16;17:12. doi: 10.1186/s12979-020-00184-y. eCollection 2020.

    PubMed 32467712
  • Lange E, Kucharski D, Svedlund S, Svensson K, Bertholds G, Gjertsson I, Mannerkorpi K. Effects of Aerobic and Resistance Exercise in Older Adults With Rheumatoid Arthritis: A Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2019 Jan;71(1):61-70. doi: 10.1002/acr.23589.

    PubMed 29696812

Questions about this trial

What is this clinical trial studying?

A study testing Person-centered high-intense training under supervision and Personalized exercise program to perform at home in people with Rheumatoid Arthritis, run by Vastra Gotaland Region at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ability to manage daily activities as measured by the rheumatoid arthritis-specific measure of the Health Assessment Questionnaire (HAQ). (time frame: 5 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02397798, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in